Stock comparison
AbbVie Inc. is 267.0x more valuable than Innoviva, Inc. by market capitalization ($438.31 B vs $1.64 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 267.0x more valuable than Innoviva, Inc. by market capitalization ($438.31 B vs $1.64 B).
Market value leader
ABBV
AbbVie Inc. is 267.0x more valuable than Innoviva, Inc. by market capitalization ($438.31 B vs $1.64 B).
Revenue leader
ABBV
INVA: $411.33M vs ABBV: $61.16B.
| Metric | INVA | ABBV |
|---|---|---|
| Market cap | $1.64 B | $438.31 B |
| US-listed rank | #2297 | #26 |
| Revenue (latest FY) | $411.33M | $61.16B |
| Net income (latest FY) | - | $4.23B |
| Net margin | - | 6.9% |
| P/E (trailing FY) | - | 103.7x |
| SEC filings | 1,653 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 267.0x more valuable than Innoviva, Inc. by market capitalization ($438.31 B vs $1.64 B).
In their latest fiscal years, Innoviva, Inc. reported $411.33M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Innoviva, Inc. and AbbVie Inc., or browse the full rankings.